FDA approves Pfizer’s new nasal spray treatment for migraines
(WASHINGTON) -- The U.S. Food and Drug Administration has approved Pfizer's newest drug on the migraine market, Zavzpret (zavegepant) -- the first and only migraine treatment of its kind to be offered in nasal spray.The drug has shown in clinical trial data to provide... Read More.